Please provide your email address to receive an email when new articles are posted on . OPTION is a head-to-head trial of left atrial appendage closure with Watchman FLX vs. anticoagulation after ...

"Atrial fibrillation and heart failure are growing epidemics, and both beget each other." ---- Jonathan Hsu, MD, MAS, University of California San Diego “Atrial fibrillation and heart failure are ...

Erlanger Cardiology completed the first in Chattanooga concomitant left atrial appendage closure (LAAC) and cardiac ablation for atrial fibrillation (AFib) on Nov. 23. Officials said, "This is an ...

The recurrence of atrial fibrillation (AF) after catheter ablation occurs in 11% to 41% of patients. 1 A recent study by Masuda and colleagues 2 reports that the presence of left atrial low-voltage ...

Millions of people around the world are diagnosed with heart failure and atrial fibrillation every year. In the weakened state, the heart is unable to pump enough oxygenated blood throughout the body.

In patients with persistent atrial fibrillation (AF), standard treatment with pulmonary vein isolation (PVI) ablation resulted in similar outcomes to more extensive ablation in other areas of the ...

Every year millions of people around the world are diagnosed with heart failure, a chronic, progressive condition where the heart is unable to pump enough oxygenated blood throughout the body.

Cryoballoon (CB) ablation is as effective at reducing recurrences of atrial fibrillation (AF) and atrial tachycardia (AT) at 1-year, when compared to the current most widely used technique, ...

TCT 736: Cost Effectiveness Analysis of the OPTION Trial: Left Atrial Appendage Closure after Ablation for Non-Valvular Atrial Fibrillation Receive the the latest news, research, and presentations ...

A significant proportion of patients undergoing atrial fibrillation (AF) ablation as part of the CABANA trial had a high probability of heart failure with preserved ejection fraction (HFpEF). These ...